Yan Wang*, Min Yu, Yue Ma, Ruoping Wang, Wei Liu, Wei Xia, Aili Guan, Conghui Xing, Fei Lu and Xiaoping Ji* Pages 11 - 18 ( 8 )
Peroxisome proliferator-activated receptors alpha (PPARα) is a therapy target in atherosclerosis and cardiovascular diseases. However, anti-inflammatory effects of PPARα in intracerebral hemorrhage (ICH) remain unknown. We investigated the anti-inflammatory effects of fenofibrate, a ligand of PPARα, in ICH rat model. We found that engagement of fenofibrate increased nissl body and astrocytes, and reduced the neuronal damage, which was observed in paraffin section of ICH rat brain. Fenofibrate also promoted the proliferation of astrocytes that were isolated from adult rat brain. Fenofibrate significantly upregulated heme oxygenase 1 (HO-1) at protein and mRNA levels in human glioblastoma LN-18 cells and rat brain astrocytes respectively, but nuclear factor kappalight- chain-enhancer of activated B cells (NFκB) was downregulated after fenofibrate treatment. Results showed that fenofibrate-induced upregulation of HO-1 expression were inhibited after LN-18 cells were transfected with 50nM small interfering RNA (siRNAs) for 48 hours to knockdown PPARα. Further studies in rat astrocytes confirmed the rescue effects of PPARα silence against fenofibrate induced upregulation of HO-1 expression. Our data indicated that fenofibrate benefits neuronal protection through increasing HO-1 expression level and decreasing NFκB expression in PPARα-dependent manner. In conclusion, PPARα and HO-1 may function as significant targets to protect the brain during ICH.
PPARα, fenofibrate, HO-1, NFκB, nissl body, astrocytes, neuronal protection, intracerebral hemorrhage.
Key Laboratory of Cardiovascular Remodeling and Function Research, QiLu Hospital, Shandong University, Jinan, 250013, P.R., Key Laboratory of Cardiovascular Remodeling and Function Research, QiLu Hospital, Shandong University, Jinan, 250013, P.R.